Q2 FY27 Results Live Updates: Anand Rathi, Can Fin Homes and Poonawalla Fincorp will be among the key earnings announcements to watch.

Q2 FY27 Results Live Updates: Anand Rathi, Can Fin Homes and Poonawalla Fincorp will be among the key earnings announcements to watch.

The Indian government and Musk sparred over the issue on Thursday after the telecom department rejected allegations that Starlink's satellite internet services were being blocked by domestic business interests, leading the tech trillionaire to ask if "Ambani is the real boss of India".

Vijay Sethupathi-starrer 'Baththa' collected Rs 1.34 crore net in India on Day 8, taking its total India net collection to Rs 15.42 crore. The film's India gross collection now stands at Rs 17.85 crore.

HCG's Ajai Kumar says the MRP can be cut, but the 30% trade margin cap on non-scheduled cancer drugs could keep new treatments from Indian patients.

'Drishyam 3: The Conclusion' wrapped up its first week with Rs 245.50 crore net in India and Rs 383.60 crore worldwide, surpassing Drishyam 2's lifetime India collection and entering Hindi cinema's top 10 first-week performers.

The Indian tech industry is "extremely well-run" and has consistently played a vital role in creating jobs globally, particularly in the US, Nasscom Chairperson Srikanth Velamakanni said.

IT Stocks Today: TCS reported a net profit of Rs 13,884 crore for the September quarter, compared with the analyst estimate of Rs 13,788 crore. Revenue stood at Rs 73,188 crore, ahead of the estimated Rs 73,026 crore.

The move puts Indian technology workers, who dominate the H-1B pool, at the centre of the fallout.

Tata Consultancy Services stated again, in an interview with NDTV Profit after their Q2 results, that they wish to be the world's leading AI-led technology services firm, as annual AI revenue exceeds $3.1 billion.

Much of the longtime TV executive who created Warner Bros, Zaslav's compensation came in the form of stock options.

TCS has built a local workforce across 31 offices and delivery centres in the country and reiterated an earlier plan to hire an additional 15,000 people in the US over the next five years.

Goldman Sachs' discussions with hospitals and industry participants suggest that the impact of the new price controls is likely to be minimal across most multi-specialty hospital chains.